Related Experiment Video

Updated: Sep 12, 2026

Parallel Measurement of Circadian Clock Gene Expression and Hormone Secretion in Human Primary Cell Cultures
06:53

Parallel Measurement of Circadian Clock Gene Expression and Hormone Secretion in Human Primary Cell Cultures

Published on: November 11, 2016

Circadian rhythms and coronary events: implications for therapy

A P Selwyn1, K Raby, A Yeung

  • 1Brigham & Women's Hospital, Department of Medicine, Boston, Mass. 02115.

Cardiology
|January 1, 1992
PubMed

Insights

Silent ischemic episodes, often occurring in the morning, indicate risk for obstructive coronary disease. Long-acting medications like calcium blockers, beta-blockers, and aspirin may help manage this risk.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Clinical Risk Assessment

Background:

  • Obstructive coronary disease presents with diverse clinical manifestations, some serving as critical risk indicators.
  • Transient myocardial ischemia, often asymptomatic, occurs during daily activities and signifies heightened vascular risk.
  • Ambulatory electrocardiogram monitoring reveals a diurnal pattern of ischemia, with increased frequency in the morning.

Purpose of the Study:

  • To investigate the occurrence and potential triggers of transient myocardial ischemia.
  • To explore the relationship between morning vascular events and ischemic episodes.
  • To evaluate the efficacy of pharmacological interventions in managing ischemia.

Main Methods:

  • Utilized ambulatory electrocardiogram monitoring to assess transient ischemia.
  • Correlated ischemic events with physiological changes during waking and rising.
  • Reviewed the impact of cardiovascular medications on ischemic patterns.

Main Results:

  • Transient ischemia occurs more frequently during morning hours, coinciding with sympathetic nervous system activation and altered coronary hemodynamics.
  • This morning period is associated with increased myocardial oxygen demand and a potentially lower threshold for ischemia.
  • Pharmacological agents including calcium blockers, beta-blockers, and aspirin demonstrate beneficial effects.

Conclusions:

  • The morning hours represent a high-risk period for silent transient ischemia in obstructive coronary disease.
  • Long-acting formulations of medications are recommended due to the temporal variability of ischemic events.
  • Understanding diurnal patterns of ischemia can inform risk stratification and therapeutic strategies.

More Related Videos

In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells11:56

In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells

Published on: September 28, 2017

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings06:39

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings

Published on: June 13, 2025

Related Concept Videos

Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...